Honeywell International Inc. · HON · FY2026 Q1 · Calendar Q2 2026
Honeywell maintains guidance as backlog and portfolio changes support growth
Honeywell's maintained FY2026 outlook is supported by backlog, order growth and margin expansion, but the evidence remains balanced by supply-chain constraints, geopolitical exposure and portfolio-transformation execution risk.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about HON FY2026 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior quarter, management reported continued order and margin momentum while moving closer to the planned Aerospace spinoff and divestitures. The call also highlighted a modest Middle East conflict impact and temporary Aerospace supply-chain constraints.
Guidance delta
Management maintained FY2026 guidance for 3–6% organic sales growth, with high-single-digit Aerospace growth and flat Process Automation and Technology sales.
Key takeaways
- Management reported 11% adjusted EPS growth and 90 basis points of margin expansion to 23.3%.
- Backlog exceeded $38 billion with book-to-bill above 1.1, supporting management's growth outlook.
- Building Automation, Aerospace and Process Automation drove order growth, including demand tied to data centers, LNG and refining projects.
- Management cited a modest 0.5–1% revenue impact from the Middle East conflict and temporary Aerospace supply-chain constraints.
- The Aerospace spinoff and planned business divestitures remain central execution milestones.
Management priorities
- Complete the Aerospace spinoff and planned divestitures
- Add supply-chain capacity and new suppliers for Aerospace
- Convert backlog and large LNG, refining and petrochemical wins into sales
- Advance the Johnson Matthey Catalyst Technologies acquisition
Follow HON with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 31, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 18, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 14, 2026 |
| B of A Securities | Neutral | Underperform | Upgrade | Jul 28, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 27, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 27, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 30, 2026 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Jun 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 10, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 3, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 24, 2026 |
| Jefferies | Hold | Hold | Maintain | Mar 4, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Feb 27, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jan 30, 2026 |
| Baird | Neutral | Neutral | Maintain | Feb 7, 2025 |
| UBS | Neutral | Sell | Upgrade | Jun 10, 2024 |
| Berenberg | Buy | Hold | Upgrade | Mar 6, 2024 |
| HSBC | Hold | Hold | Maintain | Feb 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 3, 2023 |
| Argus Research | Buy | Buy | Maintain | Feb 1, 2021 |
| Bank of America | Buy | Buy | Maintain | Nov 26, 2019 |
| Oppenheimer | Market Perform | Outperform | Downgrade | Jan 8, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Apr 23, 2018 |
| Stifel | Buy | Buy | Maintain | Apr 23, 2018 |
| Bernstein | Outperform | Outperform | Maintain | Jul 25, 2016 |
| Ladenburg Thalmann | Buy | Hold | Upgrade | Jan 27, 2014 |
| Nomura | Neutral | Buy | Downgrade | Jul 22, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $211.79. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Stephen Tusa | $231 | $211.79 | +9.1% | Sep 24, 2026 |
| Morgan Stanley | Analyst unavailable | $250 | $217.43 | +18.0% | Aug 31, 2026 |
| RBC Capital | Analyst unavailable | $293 | $229.15 | +38.3% | Aug 18, 2026 |
| Jefferies | Analyst unavailable | $255 | $229.95 | +20.4% | Aug 17, 2026 |
| Jefferies | Sheila Kahyaoglu | $175 | $246.21 | -17.4% | Aug 9, 2026 |
| Jefferies | Analyst unavailable | $265 | $245.75 | +25.1% | Jul 28, 2026 |
| UBS | Analyst unavailable | $265 | $245.81 | +25.1% | Jul 27, 2026 |
| BMO Capital | Daniel DiCicco | $276 | $243.15 | +30.3% | Jul 27, 2026 |
| RBC Capital | Analyst unavailable | $298 | $242.65 | +40.7% | Jul 24, 2026 |
| Bernstein | Analyst unavailable | $243 | $226.42 | +14.7% | Jul 12, 2026 |
| Wolfe Research | Analyst unavailable | $265 | $220.6 | +25.1% | Jul 9, 2026 |
| Deutsche Bank | Nicole Deblase | $263 | $223.75 | +24.2% | Jun 30, 2026 |
| Daiwa | Analyst unavailable | $255 | $227.8 | +20.4% | Jun 30, 2026 |
| Barclays | Analyst unavailable | $239 | $215.7 | +12.8% | Jun 10, 2026 |
| Bernstein | Varun Govindaraj | $233 | $215.7 | +10.0% | Jun 9, 2026 |
| RBC Capital | Deane Dray | $275 | $217.12 | +29.8% | Jun 5, 2026 |
| Goldman Sachs | Joe Ritchie | $276 | $235.23 | +30.3% | Jun 3, 2026 |
| Wolfe Research | Nigel Coe | $275 | $233 | +29.8% | May 29, 2026 |
| Barclays | Analyst unavailable | $251 | $231.72 | +18.5% | May 27, 2026 |
| Barclays | Analyst unavailable | $243 | $214.34 | +14.7% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $273 | $225.17 | +28.9% | Mar 26, 2026 |
| Barclays | Julian Mitchell | $275 | $246.16 | +29.8% | Mar 3, 2026 |
| Goldman Sachs | Analyst unavailable | $262 | $243.97 | +23.7% | Feb 23, 2026 |
| Jefferies | Analyst unavailable | $240 | $229.35 | +13.3% | Feb 3, 2026 |
| RBC Capital | Analyst unavailable | $268 | $228.92 | +26.5% | Jan 30, 2026 |
| Robert W. Baird | Peter Arment | $240 | $227.24 | +13.3% | Jan 30, 2026 |
| Wells Fargo | Joseph O'Dea | $235 | $227.24 | +11.0% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $259 | $227.24 | +22.3% | Jan 30, 2026 |
| Bernstein | Analyst unavailable | $255 | $215.02 | +20.4% | Jan 16, 2026 |
| RBC Capital | Analyst unavailable | $249 | $213.98 | +17.6% | Jan 15, 2026 |
| Wells Fargo | Joseph O'Dea | $215 | $204.94 | +1.5% | Jan 7, 2026 |
| Vertical Research | Jeffrey Sprague | $220 | $199.7 | +3.9% | Jan 5, 2026 |
| Mizuho Securities | Brett Linzey | $240 | $195.88 | +13.3% | Jan 5, 2026 |
| Barclays | Julian Mitchell | $250 | $195.5 | +18.0% | Dec 24, 2025 |
| Evercore ISI | Alexander Virgo | $255 | $193.64 | +20.4% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $269 | $193.47 | +27.0% | Dec 4, 2025 |
| BNP Paribas | Andrew Buscaglia | $195 | $193.15 | -7.9% | Dec 3, 2025 |
| Morgan Stanley | Analyst unavailable | $235 | $213.95 | +11.0% | Oct 28, 2025 |
| Goldman Sachs | Joe Ritchie | $245 | $218.43 | +15.7% | Oct 27, 2025 |
| Wells Fargo | Joseph O'Dea | $230 | $216.14 | +8.6% | Oct 27, 2025 |
| RBC Capital | Deane Dray | $253 | $216.14 | +19.5% | Oct 27, 2025 |
| RBC Capital | Analyst unavailable | $235 | $215.8 | +11.0% | Oct 24, 2025 |
| UBS | Analyst unavailable | $258 | $218.46 | +21.8% | Oct 24, 2025 |
| Barclays | Julian Mitchell | $247 | $213.12 | +16.6% | Mar 26, 2025 |
| Barclays | Julian Mitchell | $255 | $220.63 | +20.4% | Jan 8, 2025 |
| Wells Fargo | Joseph O'Dea | $240 | $220.63 | +13.3% | Jan 7, 2025 |
| Bank of America Securities | Andrew Obin | $230 | $209.1 | +8.6% | Oct 24, 2024 |
| Mizuho Securities | Brett Linzey | $245 | $204.67 | +15.7% | Sep 13, 2024 |
| Morgan Stanley | Chris Snyder | $210 | $202.98 | -0.8% | Sep 6, 2024 |
| RBC Capital | Deane Dray | $214 | $202.28 | +1.0% | Jul 26, 2024 |
| UBS | Damian Karas | $215 | $208.78 | +1.5% | Jun 10, 2024 |
| RBC Capital | Deane Dray | $218 | $205.6 | +2.9% | Jun 4, 2024 |
| Deutsche Bank | Nicole DeBlase | $215 | $194.04 | +1.5% | Apr 15, 2024 |
| Berenberg Bank | Philip Buller | $240 | $200.5 | +13.3% | Mar 6, 2024 |
| J.P. Morgan | Stephen Tusa | $215 | $208.26 | +1.5% | Jul 27, 2023 |
| Wells Fargo | Joseph O’Dea | $180 | $172.8 | -15.0% | Jul 17, 2022 |
| Barclays | Julian Mitchell | $204 | $169.51 | -3.7% | Jul 15, 2022 |
| Deutsche Bank | Nicole DeBlase | $211 | $169.39 | -0.4% | Jul 14, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $194 | $195.19 | -8.4% | Jun 7, 2022 |
| Wells Fargo | Joseph O’Dea | $203 | $195.43 | -4.2% | May 8, 2022 |
| Credit Suisse | Analyst unavailable | $206 | $200.34 | -2.7% | May 2, 2022 |
| Morgan Stanley | Analyst unavailable | $216 | $200.12 | +2.0% | May 2, 2022 |
| Citigroup | Analyst unavailable | $232 | $193.51 | +9.5% | May 2, 2022 |
| Deutsche Bank | Nicole DeBlase | $230 | $192.07 | +8.6% | Apr 19, 2022 |
| Cowen & Co. | Gautam Khanna | $230 | $196.03 | +8.6% | Apr 3, 2022 |
| Wells Fargo | Joseph O’Dea | $209 | $187.43 | -1.3% | Mar 5, 2022 |
| UBS | Markus Mittermaier | $220 | $182.13 | +3.9% | Feb 20, 2022 |
| Wells Fargo | Joseph O'Dea | $205 | $192.48 | -3.2% | Feb 7, 2022 |
| Citigroup | Andrew Kaplowitz | $248 | $191.5 | +17.1% | Feb 6, 2022 |
| J.P. Morgan | Stephen Tusa | $235 | $190.45 | +11.0% | Feb 4, 2022 |
| Robert W. Baird | Peter Arment | $243 | $190.69 | +14.7% | Feb 3, 2022 |
| Mizuho Securities | Brett Linzey | $235 | $190.69 | +11.0% | Feb 3, 2022 |
| Jefferies | Sheila Kahyaoglu | $230 | $203.33 | +8.6% | Jan 23, 2022 |
| Berenberg Bank | Phil Buller | $230 | $216.46 | +8.6% | Jan 14, 2022 |
| Credit Suisse | John Walsh | $226 | $209 | +6.7% | Jan 4, 2022 |
| Bank of America Securities | Andrew Obin | $245 | $203.53 | +15.7% | Dec 8, 2021 |
| Wolfe Research | Nigel Coe | $259 | $221.94 | +22.3% | Jul 12, 2021 |
Track every rating change on HON the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHoneywell International Inc. functions as a global leader in diversified technology and manufacturing. Its Aerospace division furnishes a comprehensive array of products and services for the aviation and space industries. This includes crucial components like auxiliary power units, propulsion systems, integrated avionics, environmental control mechanisms, and electrical power solutions. The segment also supplies engine controls, flight safety systems, communication and navigation hardware, and advanced data and software applications. Additionally, it provides radar, surveillance systems, aircraft lighting, sophisticated instruments, satellite and space components, and aircraft wheels and brakes. Essential support services cover spare parts, repairs, overhauls, maintenance, thermal systems, and wireless connectivity management. The Honeywell Building Technologies unit focuses on creating smarter, safer, and more efficient structures.…
Historical context
All HON earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
Get the HON recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-25T01:40:55.644716+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T01:40:55.642008+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.